Pharvaris PHVS
NASDAQ PHVS
$31.22 +0.32 (+1.02%)
As of: Oct 21, 2026 · 11:40 AM EDT

Pharvaris (PHVS) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Pharvaris (PHVS) reported Liabilities and Shareholders Equity of $382.03 million for Q2 2026, up 60.9% from $237.5 million a year earlier but down 100.0% from the prior quarter.

Analysis

Pharvaris (PHVS) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Pharvaris posted Liabilities and Shareholders Equity of $340.59 million, up 8.0% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 24.2% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $315.37 million in FY2024 (-26.9%), $431.27 million in FY2023 (+144.0%), $176.78 million in FY2022 (-29.6%) and $250.99 million in FY2021 (+117.4%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $171.13 million in Q4 2022 and a high of $410.2 trillion in Q1 2024.
  • Year over year, Liabilities and Shareholders Equity gained in three of the last seven quarters, with an average decline of 14.9%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2024 (growth of 158.6%); the low point was Q1 2025 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $304.15 trillion (Q1 2026), $350.91 million (Q4 2025) and $396.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 201.06 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 135.12 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 115.83 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 49.36 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 201.13 Bn
10 Pharvaris 1.84 Bn 466.87 Mn - 375.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 375.41 Mn
Mar 31, 2026 297.72 Mn
Dec 31, 2025 354.13 Mn
Sep 30, 2025 397.57 Mn
Jun 30, 2025 246.05 Mn
Mar 31, 2025 268.50 Mn
Dec 31, 2024 303.21 Mn
Sep 30, 2024 349.81 Mn
Jun 30, 2024 376.77 Mn
Mar 31, 2024 407.59 Mn
Dec 31, 2023 441.28 Mn
Sep 30, 2023 178.86 Mn
Jun 30, 2023 206.21 Mn
Mar 31, 2023 161.17 Mn
Dec 31, 2022 178.82 Mn
Sep 30, 2022 199.52 Mn
Jun 30, 2022 215.98 Mn
Mar 31, 2022 224.50 Mn
Dec 31, 2021 240.19 Mn
Sep 30, 2021 258.82 Mn
API Access

Pharvaris Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PHVS&period=max&api_key=YOUR_API_KEY